Befotertinib Clinical Trials
3 recruitingDrug
Phase 22Phase 41
Showing 1–3 of 3 trials
Recruiting
Phase 2
Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
NSCLCEGFRAdjuvant Drug Therapy
Betta Pharmaceuticals Co., Ltd.28 enrolled2 locationsNCT07181499
Recruiting
Phase 4
Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
3-year Disease-free Survival
Fudan University592 enrolled1 locationNCT06561620
Recruiting
Phase 2
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
Non-small Cell Lung Cancer MetastaticEGFR G719XEGFR L861Q+1 more
Sun Yat-sen University23 enrolled1 locationNCT06517953